ChordNews
← All news

Astellas Pharma reports GAAP EPS of ¥134.47 and revenue of ¥1,270.86 billion, updates FY2027 outlook

By ChordNews · First written (updated )

Comments 0

Summary

Astellas Pharma's ADR reported GAAP earnings per share of ¥134.47 and revenue of ¥1,270.86 billion, and updated its outlook for fiscal 2027, according to Seeking Alpha. The report gives no detail on the direction or size of the outlook change, or on any drivers behind the results.

This continues an earlier story: Murata Manufacturing reports GAAP EPS of ¥102.40 and revenue of ¥1,090.76 billion, updates FY2027 outlook

Later: Mitsubishi Heavy Industries reports GAAP EPS of ¥60.47 and revenue of ¥2.52 billion, updates fiscal-year outlook

Timeline

  1. Seeking Alpha

    Source ↗

    Seeking Alpha reports that Astellas Pharma's ADR posted GAAP EPS of ¥134.47 and revenue of ¥1,270.86 billion, and updated its FY2027 outlook.

Comments

No comments yet.

    to like and comment.

    © 2026 ChordNews